Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00177554
Status:
COMPLETED
Last Update Posted:
2008-05-29
First Post:
2005-09-13
Brief Title:
Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Organization Data
Organization:
University of Pittsburgh
Class:
OTHER
Study ID:
UPCI 03-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Pittsburgh
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Samuel JacobsMD
Old Organization:
University of Pittsburgh cancer Institute
Collaborators
| Name | Class |
|---|---|
| Biogen | INDUSTRY |